BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

OXFORD ASSET MANAGEMENT LLP's Holding History (CIK: 0001438284)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 66,618 Value ($000) $597 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 20,217 Value ($000) $152 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 13,165 Value ($000) $99 Avg Close $7.59 Range $6.85 - $8.44
Q3 2018
Shares 98,284 Value ($000) $747 Avg Close $6.72 Range $5.41 - $8.13
Q2 2018
Shares 200,921 Value ($000) $1,169 Avg Close $5.50 Range $4.53 - $6.67
Q1 2018
Shares 330,731 Value ($000) $1,578 Avg Close $5.14 Range $4.25 - $5.92
Q4 2017
Shares 237,000 Value ($000) $1,206 Avg Close $4.84 Range $4.12 - $5.35
Q3 2017
Shares 11,572 Value ($000) $61 Avg Close $5.12 Range $3.95 - $6.22
Q2 2017
Shares 118,674 Value ($000) $660 Avg Close $6.09 Range $5.02 - $8.80
Q4 2015
Shares 10,598 Value ($000) $110 Avg Close $9.94 Range $8.01 - $12.88
Q3 2015
Shares 233,481 Value ($000) $2,662 Avg Close $13.34 Range $10.26 - $16.83
Q3 2014
Shares 208,851 Value ($000) $2,071 Avg Close $12.26 Range $9.78 - $14.62
Q2 2014
Shares 293,605 Value ($000) $3,732 Avg Close $9.73 Range $7.29 - $12.86